AstraZeneca Pharma India to launch cancer drug Enhertu in January

Enhertu, an antibody-drug conjugate, is being used in the treatment of HER2-positive metastatic breast cancer in a number of countries globally

from Companies https://ift.tt/ZPaM9jJ